About the Company
We do not have any company description for Maze Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Maze Therapeutics, Inc.
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright ...
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for ...
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive ...
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease ...
Maze Therapeutics receives positive ratings following recent IPO
Investing.com -- Maze Therapeutics Inc (NASDAQ:MAZE) received bullish coverage from multiple analysts, with Guggenheim, JPMorgan, and TD Cowen initiating Buy or Overweight ratings on the company ...
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney ...
Maze Therapeutics, Inc.: Maze Therapeutics Reports Fourth Quarter and ...
MAZE THERAPEUTICS INC WKN: A41188|ISIN: US5787841007|Ticker-Symbol: NASDAQ 05.08.25 | 21:32 14,160US-Dollar -6,90 % -1,050 Branche Biotechnologie Aktienmarkt Sonstige 1-Jahres-Chart 5-Tage-Chart ...
Maze Therapeutics Announces Pricing of Upsized Initial Public Offering
Investors: Jillian Connell, Maze Therapeutics jconnell@mazetx.com (650) 850-5080 Media: Dan Budwick, 1AB dan@1abmedia.com Source: Maze Therapeutics, Inc. 2025 GlobeNewswire, Inc.
Maze Therapeutics, Inc.: Maze Therapeutics Reports First Quarter 2025 ...
SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for ...
Maze Therapeutics Inc. (MAZE) Stock Price Today - WSJ
View the latest Maze Therapeutics Inc. (MAZE) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients ...
BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to ...
--BridgeBio Pharma, Inc. and Maze Therapeutics today announced the establishment of a joint venture, Contour Therapeutics, focused on transforming and advancing breakthrough precision medicine ...
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright ...
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for ...
Similar Companies
Loading the latest forecasts...